Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s76, 2022. DOI: 10.25251/skin.6.supp.76. Disponível em: https://skin.dermsquared.com/skin/article/view/1834. Acesso em: 17 may. 2025.